Combined bottle and cap
Latest Bristol-Myers Squibb Company Patents:
- METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3
- Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
- Substituted thienopyrroles as PAD4 inhibitors
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
Description
FIG. 1 is a top, front perspective view of a combined bottle and cap showing my new design;
FIG. 2 is a bottom perspective view thereof;
FIG. 3 is a top plan view thereof;
FIG. 4 is a side elevational view thereof, the opposite side elevational view is the same; and,
FIG. 5 is a bottom view thereof.
Referenced Cited
U.S. Patent Documents
Other references
D183424 | August 1958 | Goldberg |
3223269 | December 1965 | Williams |
3244272 | April 1966 | Beaman et al. |
- Armstrong Closures Catalog, 1948, p. 11, Artmold Caps. Drug & Cosmetic Industry, Mar. 1983, p. 83 bottle and cap, top photograph on left side., Packaging, May 1983, p. 34, bottle and cap, bottom right photograph.
Patent History
Patent number: D357865
Type: Grant
Filed: Jan 18, 1994
Date of Patent: May 2, 1995
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Elizabeth A. Hansen (Cary, NC)
Primary Examiner: Lucy J. Lieberman
Attorney: Anthony M. Santini
Application Number: 0/17,574
Type: Grant
Filed: Jan 18, 1994
Date of Patent: May 2, 1995
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Elizabeth A. Hansen (Cary, NC)
Primary Examiner: Lucy J. Lieberman
Attorney: Anthony M. Santini
Application Number: 0/17,574
Classifications
Current U.S. Class:
D/9503;
D/9453